Coldrex SWOT Analysis, USP & Competitors

Posted in FMCG, Total Reads: 1722
Advertisements

SWOT Analysis of Coldrex with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

‘Coldrex’

Parent Company

GSK

Category

Healthcare

Sector

FMCG

Tagline/ Slogan

‘For the rapid and effective relief from cold & flu symptoms’

USP

All Coldrex products contain paracetamol and other active ingredients that are specifically formulated to relieve cold & flu symptoms, so they will provide much more effective relief than a general pain reliever.

STP

Segment

OTC medicine

Target Group

Masses

Positioning

Provides relief from major cold & flu symptoms

SWOT Analysis

Strengths

1. Very well accepted in the European markets and enjoys the trust associated with GSK brand.
2. GSK has a strong presence in pharmaceutical products with world class R&D and product innovation, the brand benefits from that.

3. A wide range of products available in different pack sizes to address needs of different consumers

Weaknesses

1.The brand has almost negligible presence in India, an emerging market with promising opportunities

2. Have been reported to cause side-effects in some people.

Opportunities

1. Target the alternative channels and promote it through medical representatives

2. Advertise on mass media to enhance recall

Threats

1. Not much awareness in the market regarding the effectiveness of the product.
2. Lot of competition in the market.

Competition

Competitors

1. generic drugs

2. Panadol  cold and flu



Advertisements



Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.